Skip to content
Trial Eligibility
Menu

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

NCT07142356

This study is recruiting at 33 US sites in 17 states, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this clinical trial is to measure the safety and efficacy of RTN-001 in adult participants with uncontrolled hypertension versus placebo.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Uncontrolled Hypertension

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
18 to 75 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Retension Pharmaceuticals. Inc.
Last updated on ClinicalTrials.gov
October 2, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Alabama · 2

  • Retension Clinical Site · Alexander City, AL
  • Retension Clinical Site · Birmingham, AL

Arizona · 1

  • Retension Clinical Site · Tucson, AZ

California · 2

  • Retension Clinical Site · San Jose, CA
  • Retension Clinical Site · West Hills, CA

Connecticut · 1

  • Retension Clinical Site · Waterbury, CT

Florida · 4

  • CRO Call Center · Maitland, FL
  • Retension Clinical Site · Orlando, FL
  • Retension Clinical Site · Port Orange, FL
  • Retension Clinical Site · Tampa, FL

Georgia · 3

  • CRO Call Center · Decatur, GA
  • Retension Clinical Site · Lawrenceville, GA
  • Retension Clinical Site · Peachtree Corners, GA

Indiana · 2

  • CRO Call Center · Indianapolis, IN
  • CRO Call Center · Munster, IN

Louisiana · 1

  • CRO Call Center · New Orleans, LA

Massachusetts · 2

  • Retension Clincial Site · Boston, MA
  • CRO Call Center · Methuen, MA

Missouri · 1

  • CRO Call Center · Overland, MO

Nevada · 2

  • Retension Clinical Site · Las Vegas, NV
  • Retension Clinical Site · Las Vegas, NV

New York · 1

  • Retension Clinical Site · The Bronx, NY

North Carolina · 3

  • Retension Clinical Site · Asheboro, NC
  • Retension Clinical Site · Charlotte, NC
  • Retension Clinical Site · Monroe, NC

Ohio · 1

  • Retension Clinical Site · Cincinnati, OH

South Carolina · 1

  • Retension Clinical Site · Charleston, SC

Texas · 5

  • Retension Clinical Site · Bellaire, TX
  • Retension Clinical Site · Dallas, TX
  • Retension Clincal Site · Plano, TX
  • Retension Clinical Site · San Antonio, TX
  • Retension Clinical Site · Sugar Land, TX

Virginia · 1

  • Retension Clinical Site · Vienna, VA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.